The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
NCT ID: NCT04142827
Last Updated: 2019-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
160 participants
INTERVENTIONAL
2019-09-04
2020-09-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of AIRVO Heated Humidification in Bronchiectasis
NCT04102774
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
NCT01552031
Bacteriology and Inflammation in Bronchiectasis
NCT01761214
Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound
NCT01080924
Functional Respiratory Imaging in Bronchiectasis
NCT03818646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapy with high flow humidification
The patients will be activated after enrollment with myAirvo2 device at home for 6 months before first observations
High Flow Humidification
myAirvo2 gives at home for long therapy treatment
Therapy with usual care
The patients will be under usual care for observational
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Flow Humidification
myAirvo2 gives at home for long therapy treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Optimization of Therapy for at least 15 days before enrollment
* Autonomous patients with possibilities of practicing rehabilitations cycles
Exclusion Criteria
* HOME NIV
* PH\<7,35 - paO2\< 60mmHg, paCo2\> 55 mmHg
* Lung cancer
* Contraindication to high-flow nasal cannula (hfnc)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Giuseppe Fiorentino
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Giuseppe Fiorentino
Director Giuseppe Fiorentino
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rosa Cauteruccio
Napoli, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
High Flow in Bronchiectasis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.